Pages that link to "Q57958494"
Jump to navigation
Jump to search
The following pages link to Gianenrico Senna (Q57958494):
Displaying 50 items.
- Therapeutic interventions in severe asthma (Q28079238) (← links)
- EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy (Q30394524) (← links)
- Sublingual immunotherapy: World Allergy Organization position paper 2013 update (Q30440195) (← links)
- In chronic idiopathic urticaria autoantibodies against Fc epsilonRII/CD23 induce histamine release via eosinophil activation. (Q33230891) (← links)
- A double-blind, placebo-controlled study on the diagnostic accuracy of an electrodermal test in allergic subjects. (Q34131626) (← links)
- The perception of Obstructive Sleep Apnoea/Hypopnoea Syndrome (OSAHS) among Italian general practitioners (Q35424694) (← links)
- Prospective adherence to specific immunotherapy in Europe (PASTE) survey protocol. (Q35540640) (← links)
- Choosing wisely: practical considerations on treatment efficacy and safety of asthma in the elderly (Q35765263) (← links)
- Drop-out rate among patients treated with omalizumab for severe asthma: Literature review and real-life experience. (Q36113704) (← links)
- 360 degree perspective on allergic rhinitis management in Italy: a survey of GPs, pharmacists and patients (Q36238142) (← links)
- Asthma under/misdiagnosis in primary care setting: an observational community-based study in Italy. (Q36281473) (← links)
- Research needs in allergy: an EAACI position paper, in collaboration with EFA. (Q36517533) (← links)
- Intimate behavior and allergy: a narrative review (Q37021036) (← links)
- Fatal asthma; is it still an epidemic? (Q37501735) (← links)
- Asthma control in primary care: the results of an observational cross-sectional study in Italy and Spain (Q37739402) (← links)
- An evidence-based appraisal of the surrogate markers of efficacy of allergen immunotherapy (Q37889057) (← links)
- Allergy and the bone: unexpected relationships. (Q37923545) (← links)
- The additional values of microarray allergen assay in the management of polysensitized patients with respiratory allergy (Q38124403) (← links)
- Balancing efficacy against safety in sublingual immunotherapy with inhalant allergens: what is the best approach? (Q38149941) (← links)
- Safety and tolerability of sublingual immunotherapy in clinical trials and real life (Q38152657) (← links)
- Dropouts in sublingual allergen immunotherapy trials - a systematic review (Q38199748) (← links)
- Potential benefit of omalizumab in respiratory diseases (Q38274300) (← links)
- Omalizumab for severe allergic asthma in clinical trials and real-life studies: what we know and what we should address. (Q38339722) (← links)
- Respiratory allergies in childhood: Recent advances and future challenges. (Q38637947) (← links)
- Allergic rhinitis: pharmacotherapy in pregnancy and old age. (Q38833851) (← links)
- Periostin: The bone and beyond. (Q39034836) (← links)
- The clinical characteristics of respiratory allergy in immigrants in northern Italy. (Q39187901) (← links)
- Reslizumab and Eosinophilic Asthma: One Step Closer to Precision Medicine? (Q39201543) (← links)
- Anaphylaxis and intimate behaviour. (Q39457470) (← links)
- Recommendations for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: a GA(2) LEN taskforce position paper. (Q39774262) (← links)
- Sensitization to horse allergens in Italy: a multicentre study in urban atopic subjects without occupational exposure (Q39972464) (← links)
- Phenotyping asthma in the elderly: allergic sensitization profile and upper airways comorbidity in patients older than 65 years. (Q40091552) (← links)
- Asthma management among allergists in Italy: results from a survey. (Q40201883) (← links)
- What lies beyond Asthma Control Test: Suggestions for clinical practice. (Q40786388) (← links)
- Clinical efficacy and safety of local nasal immunotherapy. (Q41503800) (← links)
- COPD prevalence in a north-eastern Italian general population. (Q41687635) (← links)
- SANI-Severe Asthma Network in Italy: a way forward to monitor severe asthma. (Q42365050) (← links)
- How much specific is the association between hymenoptera venom allergy and mastocytosis? (Q42457384) (← links)
- Omalizumab management beyond clinical trials: the added value of a network model. (Q42642187) (← links)
- Sublingual tryptase and ECP in children treated with grass pollen sublingual immunotherapy (SLIT): safety and immunologic implications. (Q43795644) (← links)
- Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels (Q43992711) (← links)
- Food-specific IgG4 lack diagnostic value in adult patients with chronic urticaria and other suspected allergy skin symptoms. (Q44201495) (← links)
- Wasp venom allergy screening with recombinant allergen testing. Diagnostic performance of rPol d 5 and rVes v 5 for differentiating sensitization to Vespula and Polistes subspecies (Q46616496) (← links)
- Shrimp allergy in Italian adults: a multicenter study showing a high prevalence of sensitivity to novel high molecular weight allergens. (Q47357070) (← links)
- Spontaneous pneumomediastinum complicating severe acute asthma exacerbation in adult patients (Q47750031) (← links)
- Pattern of use and diagnostic value of complementary/alternative tests for adverse reactions to food. (Q47753449) (← links)
- Serum periostin during omalizumab therapy in asthma: A tool for patient selection and treatment evaluation (Q47754828) (← links)
- Evaluation of asthma control in the pharmacy: an Italian cross-sectional study. (Q47779329) (← links)
- Latex-jujube cross-reactivity: case report and immunological study. (Q47787130) (← links)
- Chronic Urticaria Patient Perspective (CUPP): The First Validated Tool for Assessing Quality of Life in Clinical Practice. (Q47803256) (← links)